Vaccine: X · Published 2026-06-03 · DOI 10.1016/j.jvacx.2026.100850
Christopher Clarke, Amanda K. Buttery, Woo Joo Kim, Masafumi Seki, Yu-Ting Tsao, Asok Kurup, Piyali Mukherjee, Ivan F.N. Hung
Reduced COVID-19 surveillance and control measures have contributed to perceptions of diminished disease severity. To contextualise post-pandemic regional activity in Asia-Pacific, publicly available COVID-19 and influenza data were reviewed across Australia, Hong Kong, Japan, Korea, Singapore (July 2024–June 2025) and Taiwan (September 2024–June 2025). National and sentinel systems reporting laboratory-confirmed infections, hospitalisations, severe or fatal cases were identified. Annual counts were summarised using country-specific definitions.Surveillance approaches and indicators varied across jurisdictions and pathogens; results are presented descriptively. Across settings, both viruses were associated with substantial morbidity and mortality. COVID-19 mortality exceeded influenza in Australia (2981 vs 1041), and hospitalisations were higher in Korea (11,786 vs 8740). In Hong Kong, severe and fatal influenza cases exceeded COVID-19 (899 vs 468), despite similar case counts (13,941 vs 14,977). Japan, Singapore and Taiwan showed comparable activity.Results indicate continued co-circulation of COVID-19 and influenza. Harmonised surveillance and definitions are needed to improve disease monitoring and guide prevention strategies.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Clarke, C., Buttery, A., Kim, W., et al. (2026). Descriptive comparison of COVID-19 and influenza in Asia-Pacific in 2024–2025. Vaccine: X. https://doi.org/10.1016/j.jvacx.2026.100850